 ENCINITAS, Calif., Nov. 22, 2022 GLOBE NEWSWIRE -- Ventyx Biosciences, Inc. Nasdaq: VTYX Ventyx, a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that Company executives will provide a company overview during fireside chats at the following upcoming investor conferences: 